Beijing Tiantan Biological Products (SHSE:600161) Total Stockholders Equity : ¥10,139 Mil (As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Total Stockholders Equity?

Beijing Tiantan Biological Products's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥10,139 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Beijing Tiantan Biological Products's Book Value per Share for the quarter that ended in Mar. 2024 was ¥6.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Beijing Tiantan Biological Products's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Beijing Tiantan Biological Products Total Stockholders Equity Historical Data

The historical data trend for Beijing Tiantan Biological Products's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Total Stockholders Equity Chart

Beijing Tiantan Biological Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

3,938.90

4,517.95

8,052.03

8,795.08

9,822.58

Beijing Tiantan Biological Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															9,057.65	9,280.15	9,600.75	9,822.58	10,139.25

Beijing Tiantan Biological Products (SHSE:600161) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Beijing Tiantan Biological Products's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(10139.253	-	0)	/	1647.81
	=	6.15

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Beijing Tiantan Biological Products's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14.71	+	27.51)	/	10139.253
	=	0.00

Beijing Tiantan Biological Products Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tiantan Biological Products (SHSE:600161) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024

Website

http://www.tiantanbio.com

Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.

Executives

Wang Jian Ming	Supervisors
Liu Ya Na	Directors, senior managers
Fu Dao Xing	Directors, senior managers
He Yan Lin	Directors, senior managers
Hu Li Gang	Director
Ci Xiang	senior management
Yang Hui Chuan	Director
Zhang Yi	senior management
Wu Zhen Shan	senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines